Cargando…

Clinical response and hospital costs associated with the empirical use of vancomycin and linezolid for hospital-acquired pneumonia in a Chinese tertiary care hospital: a retrospective cohort study

AIMS: To evaluate clinical outcomes and allocation of hospital costs associated with empirical use of vancomycin or linezolid for hospital-acquired pneumonia (HAP) in the People’s Republic of China. METHODS: Hospital episodes including HAP treated by vancomycin or linezolid between 2008 and 2012 in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Yuanlin, Yang, Yicheng, Chen, Wendong, Liu, Wei, Wang, Kai, Li, Xuehai, Wang, Ke, Papadimitropoulos, Manny, Montgomery, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207441/ https://www.ncbi.nlm.nih.gov/pubmed/25378939 http://dx.doi.org/10.2147/CEOR.S65900

Ejemplares similares

Linezolid for the treatment of hospital-acquired pneumonia in a Chinese tertiary hospital
por: Lesher, Beth A, et al.
Publicado: (2015)

Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis
por: Kalil, Andre C, et al.
Publicado: (2013)

Pneumonia Caused by Community-Acquired Methicillin-Resistant Staphylococcus aureus: Vancomycin or Linezolid?
por: Tian, Ye, et al.
Publicado: (2018)

Comparative-effectiveness of vancomycin and linezolid as part of guideline-recommended empiric therapy for healthcare-associated pneumonia
por: Reveles, Kelly R., et al.
Publicado: (2015)

Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens
por: Rubinstein, Ethan, et al.
Publicado: (2011)

Emergence of linezolid-resistant Enterococcus faecium in a tertiary hospital in Copenhagen
por: Misiakou, Maria-Anna, et al.
Publicado: (2023)

2196. Impact of Rapid Discontinuation of Empiric Vancomycin in Patients with Hospital-Acquired or Healthcare-Associated Pneumonia and Absence of Adequate Respiratory Tract Culture Data
por: Rufe, Alanna H, et al.
Publicado: (2019)

Empiric antibiotic selection for community-acquired pneumonia in US hospitals, 2013–2020
por: Wolford, Hannah, et al.
Publicado: (2023)

Emergence of linezolid-resistant Staphylococcus epidermidis in the tertiary children’s hospital in Cracow, Poland
por: Kosecka-Strojek, Maja, et al.
Publicado: (2020)

Continuous Versus Intermittent Linezolid Infusion for Critically Ill Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: Efficacy and Safety Challenges
por: Warda, Ahmed E. Abou, et al.
Publicado: (2022)

Linezolid vs Vancomycin in Induced Thrombocytopenia
por: Al-Harbi, Dimah, et al.
Publicado: (2022)

Multidrug-Resistant Infections Among Hospitalized Adults With Community-Acquired Pneumonia In An Indonesian Tertiary Referral Hospital
por: Purba, Abdul KR, et al.
Publicado: (2019)

Effectiveness, safety, and cost of vancomycin and linezolid in Kuwait: A retrospective cohort study
por: Alghanem, Sarah S., et al.
Publicado: (2023)

Low Prevalence of Cfr-Mediated Linezolid Resistance among Methicillin-Resistant Staphylococcus aureus in a Spanish Hospital: Case Report on Linezolid Resistance Acquired during Linezolid Therapy
por: Sierra, Josep M., et al.
Publicado: (2013)

Molecular Characterization of Clinical Linezolid-Resistant Staphylococcus epidermidis in a Tertiary Care Hospital
por: Campmann, Florian, et al.
Publicado: (2023)

Vancomycin and Linezolid-Resistant Enterococcus Isolates from a Tertiary Care Center in India
por: Sengupta, Mallika, et al.
Publicado: (2023)

Linezolid-resistant enterococci in Polish hospitals: species, clonality and determinants of linezolid resistance
por: Gawryszewska, I., et al.
Publicado: (2017)

Comparison of Empiric Antibiotic Escalation Therapy with Vancomycin (VAN) versus Linezolid (LIN) in Patients with Febrile Neutropenia
por: Mayer, Karin, et al.
Publicado: (2022)

Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study
por: Vissink, Conrad E., et al.
Publicado: (2016)

The impact of initial antibiotic therapy (linezolid, vancomycin, daptomycin) on hospital length of stay for complicated skin and soft tissue infections
por: Szczypinska, Ewa, et al.
Publicado: (2013)

Supportive Care Costs Associated with Second-Line Chemotherapy in Chinese Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study
por: Li, Xiaoling, et al.
Publicado: (2015)

Comprehensive risk assessment for hospital-acquired pneumonia: sociodemographic, clinical, and hospital environmental factors associated with the incidence of hospital-acquired pneumonia
por: Kim, Bo-Guen, et al.
Publicado: (2022)

Empiric Antibiotic Therapy in the Treatment of Community-acquired Pneumonia in a General Hospital in Saudi Arabia
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2019)

No Outbreak of Vancomycin and Linezolid Resistance in Staphylococcal Pneumonia over a 10-Year Period
por: Yayan, Josef, et al.
Publicado: (2015)

Emergence of optrA-Mediated Linezolid-Nonsusceptible Enterococcus faecalis in a Tertiary Care Hospital
por: Park, Kuenyoul, et al.
Publicado: (2020)

Genomic and Phenotypic Analysis of Linezolid-Resistant Staphylococcus epidermidis in a Tertiary Hospital in Innsbruck, Austria
por: Huber, Silke, et al.
Publicado: (2021)

Dynamic Changes of Staphylococcus aureus Susceptibility to Vancomycin, Teicoplanin, and Linezolid in a Central Teaching Hospital in Shanghai, China, 2008–2018
por: Jian, Ying, et al.
Publicado: (2020)

Detection of Mycoplasma pneumoniae in Mexican children with community-acquired pneumonia: experience in a tertiary care hospital
por: Merida-Vieyra, Jocelin, et al.
Publicado: (2019)

Erratum to: Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study
por: Vissink, Conrad E., et al.
Publicado: (2016)

Activity of vancomycin combined with linezolid against clinical vancomycin-resistant Enterococcus strains
por: Aktas, Gulseren
Publicado: (2020)

Bacterial etiology and mortality rate in community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia in Thai university hospital
por: Poovieng, Jaturon, et al.
Publicado: (2022)

In Vitro Activity of Vancomycin, Teicoplanin, Linezolid and Daptomycin Against Methicillin-Resistant Staphylococcus aureus Isolates Collected from Chinese Hospitals in 2018–2020
por: Xu, Yanlei, et al.
Publicado: (2021)

1472. Antibiotic De-escalation Compared with Continued Empirical Treatment in Non-Ventilated Hospital-Acquired Pneumonia
por: Alnaimi, Shaikha, et al.
Publicado: (2018)

Impact of empirical oseltamivir discontinuation in hospitalized patients with community-acquired pneumonia after confirmed negative for influenza
por: Alghanem, Ashjan F., et al.
Publicado: (2021)

Use of MRSA Nasal Swab to Guide Empiric Antibiotic Treatment of Hospital Acquired or Community Acquired Pneumonia in a Pediatric Population
por: Linfesty, Daniel, et al.
Publicado: (2017)

Pharmacodynamics of vancomycin in elderly patients aged 75 years or older with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia
por: Mizokami, Fumihiro, et al.
Publicado: (2013)

The influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia
por: Mizuno, Tomohiro, et al.
Publicado: (2013)

799 Linezolid vs Vancomycin in the Treatment of Nosocomial Pneumonia: A Cost-effectiveness Analysis Incorporating Results from the ZEPHyR Trial
por: Collins, Curtis, et al.
Publicado: (2014)

Costs of two vancomycin-resistant enterococci outbreaks in an academic hospital
por: van der Pol, Simon, et al.
Publicado: (2023)

Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin
por: Estes, Kerry S, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_dver00gis4346fh6252tki4dcv